[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?].

Ann Pharm Fr

Membre de l'Académie nationale de pharmacie, Paris, France; Centre d'études internationales et européennes EA 7307/CNRS FR 3241, université de Strasbourg, Strasbourg, France. Electronic address:

Published: July 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453175	PMC
http://dx.doi.org/10.1016/j.pharma.2020.04.001	DOI Listing

Publication Analysis

Top Keywords

[cov19 seroprevalence

seroprevalence studies

studies individuals

individuals protection

protection committees

committees aren't

aren't technological

technological organizational

organizational challenges

[cov19

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!